Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in heart failure patients with obesity, the company said Thursday.

The popular obesity drug Wegovy cuts the risk of cardiovascular events, such as heart attack and stroke, by 20%, drugmaker Novo Nordisk said Tuesday.

Wegovy shown to cut risk of stroke and heart attacks, company says The findings are the first to demonstrate that a weight-loss drug has medical benefits beyond weight reduction. Aug. 8, 2023, 12: ...

Nearly half of all Americans, according to the American Heart Association, are afflicted with a cardiovascular disease (CVD)—a group of disorders that includes strokes, heart failure, heart ...

One of Des Moines' oldest companies is sporting a new logo. The 113-year-old, Des Moines-based EMC Insurance Cos. unveiled the new look along with a new tagline Tuesday. It was the firm’s first ...

SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J. & CHICAGO, March 27, 2025--Kardigan, a heart health company modernizing cardiovascular (CV) drug development, announced today that it has acquired ...